cas 1396762-43-8|| where to buy 4-cyclopropylthiazole-2-carbohydrazide

Nombre del producto:4-cyclopropylthiazole-2-carbohydrazide

IUPAC Name:4-cyclopropyl-1,3-thiazole-2-carbohydrazide

Unidad de embalaje	Stock disponible	Precio($)
CM110741-100mg	in stock	ǧƱƱ
CM110741-250mg	in stock	ƙƱƱ
CM110741-1g	in stock	ȦǕǕ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1396762-43-8 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :1396762-43-8; Fórmula molecular:C7H9N3OS; Punto de fusión:-; Código de sonrisas:O=C(C1=NC(C2CC2)=CS1)NN; Densidad:

: Número de catálogo:CM110741; Peso molecular:183.23; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Thiazoles; Thiazoles are very important functional groups in medicinal chemistry. They act as ligands on a variety of biological matrices. Thiazoles are used in a wide range of therapeutic applications, such as antibacterial, antiretroviral, antifungal, antiallergic, antihypertensive, pain treatment, and to control symptoms of schizophrenia.

: Cyclopropanes; Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.